Long-term bone health in childhood cancer survivors: underappreciated and undertreated?

Lancet Diabetes Endocrinol. 2023 Jan;11(1):2-3. doi: 10.1016/S2213-8587(22)00315-1. Epub 2022 Dec 10.

Authors

Cornelia S Link-Rachner¹, Tilman D Rachner²

Affiliations

¹ Division of Hematology and Oncology, Department of Medicine I, Technische Universität Dresden, 01309 Dresden, Germany; National Center for Tumor Diseases, Dresden, Germany.
² Division of Endocrinology, Diabetes, and Bone Diseases, Department of Medicine III, Technische Universität Dresden, 01309 Dresden, Germany; German Cancer Consortium (DKTK), partner site Dresden, Germany. Electronic address: tilman.rachner@uniklinikum-dresden.de.

PMID: 36513117
DOI: 10.1016/S2213-8587(22)00315-1

No abstract available

Publication types

Comment

MeSH terms

Bone Density
Bone and Bones
Cancer Survivors*
Child
Humans
Neoplasms* / epidemiology
Neoplasms* / therapy